Régent Laporte

1.7k total citations · 1 hit paper
29 papers, 1.4k citations indexed

About

Régent Laporte is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Social Psychology. According to data from OpenAlex, Régent Laporte has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 9 papers in Social Psychology. Recurrent topics in Régent Laporte's work include Neuroendocrine regulation and behavior (9 papers), Electrolyte and hormonal disorders (8 papers) and Sepsis Diagnosis and Treatment (8 papers). Régent Laporte is often cited by papers focused on Neuroendocrine regulation and behavior (9 papers), Electrolyte and hormonal disorders (8 papers) and Sepsis Diagnosis and Treatment (8 papers). Régent Laporte collaborates with scholars based in United States, Canada and Switzerland. Régent Laporte's co-authors include Kathleen G. Morgan, Arie Horowitz, Ismail Laher, Inkyeom Kim, Chantal Dessy, Carrie Sougnez, Daniel Henrion, Pierre Rivière, Kazimierz Wiśniewski and Claudio D. Schteingart and has published in prestigious journals such as Physiological Reviews, PLoS ONE and The Journal of Physiology.

In The Last Decade

Régent Laporte

29 papers receiving 1.4k citations

Hit Papers

Mechanisms of smooth muscle contraction 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Régent Laporte United States 16 655 450 263 186 162 29 1.4k
Timothy V. Murphy Australia 24 803 1.2× 802 1.8× 431 1.6× 179 1.0× 229 1.4× 62 1.8k
Ilari Paakkari Finland 26 616 0.9× 416 0.9× 249 0.9× 131 0.7× 408 2.5× 92 1.8k
Takamura Muraki Japan 23 689 1.1× 394 0.9× 221 0.8× 150 0.8× 301 1.9× 103 1.8k
Jamshid Latifpour United States 21 443 0.7× 439 1.0× 125 0.5× 79 0.4× 227 1.4× 75 1.4k
Raheela Khan United Kingdom 25 738 1.1× 119 0.3× 202 0.8× 260 1.4× 155 1.0× 70 1.7k
R. Clinton Webb United States 25 509 0.8× 515 1.1× 320 1.2× 97 0.5× 63 0.4× 64 1.5k
Víctor M. Víctor Spain 23 666 1.0× 352 0.8× 187 0.7× 302 1.6× 82 0.5× 48 1.8k
Carmen Montiel Spain 25 1.0k 1.6× 210 0.5× 129 0.5× 282 1.5× 505 3.1× 54 1.9k
Fangwen Rao United States 26 791 1.2× 306 0.7× 348 1.3× 170 0.9× 335 2.1× 61 1.9k
Ingolf Gath Germany 12 512 0.8× 1.3k 2.9× 451 1.7× 55 0.3× 181 1.1× 18 1.9k

Countries citing papers authored by Régent Laporte

Since Specialization
Citations

This map shows the geographic impact of Régent Laporte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Régent Laporte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Régent Laporte more than expected).

Fields of papers citing papers by Régent Laporte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Régent Laporte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Régent Laporte. The network helps show where Régent Laporte may publish in the future.

Co-authorship network of co-authors of Régent Laporte

This figure shows the co-authorship network connecting the top 25 collaborators of Régent Laporte. A scholar is included among the top collaborators of Régent Laporte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Régent Laporte. Régent Laporte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Croston, Glenn, et al.. (2023). Selective Partial Agonism of Vasopressin 1a Receptors In Vitro by OCE-205. Journal of Pharmacology and Pharmacotherapeutics. 14(1). 54–61. 3 indexed citations
2.
Hargrove, Diane M., Sudarkodi Alagarsamy, Glenn Croston, et al.. (2020). Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome. Journal of Pharmacology and Experimental Therapeutics. 373(2). 193–203. 41 indexed citations
3.
Wiśniewski, Kazimierz, John E. Kraus, Karthik Srinivasan, et al.. (2019). Discovery of Potent, Selective, and Short-Acting Peptidic V2 Receptor Agonists. Journal of Medicinal Chemistry. 62(10). 4991–5005. 7 indexed citations
4.
Blakytny, Robert, et al.. (2016). Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit. PLoS ONE. 11(10). e0165422–e0165422. 4 indexed citations
5.
He, Xinrong, Fuhong Su, Fabio Silvio Taccone, et al.. (2015). A Selective V1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*. Critical Care Medicine. 44(1). 23–31. 58 indexed citations
6.
Maybauer, Marc O., Dirk M. Maybauer, Perenlei Enkhbaatar, et al.. (2014). The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis*. Critical Care Medicine. 42(7). e525–e533. 51 indexed citations
7.
Su, Fuhong, Xinrong He, Fabio Silvio Taccone, et al.. (2012). 123. Critical Care Medicine. 40. 1–328. 4 indexed citations
8.
Rehberg, Sebastian, Perenlei Enkhbaatar, Kazimierz Wiśniewski, et al.. (2012). Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor*. Critical Care Medicine. 40(6). 1957–1960. 11 indexed citations
9.
Laporte, Régent, Halina Wiśniewska, Sudarkodi Alagarsamy, et al.. (2011). Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1a Receptor Full Agonist for the Treatment of Vasodilatory Hypotension. Journal of Pharmacology and Experimental Therapeutics. 337(3). 786–796. 29 indexed citations
10.
Simon, Florian, Angelika Scheuerle, Michael Gröger, et al.. (2009). Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Critical Care. 13(4). R113–R113. 40 indexed citations
11.
Wiśniewski, Kazimierz, Robert Galyean, Sudar Alagarsamy, et al.. (2009). Synthesis and in vitro Pharmacological Profile of Potent and Selective Peptidic V1a Receptor Agonists.. Advances in experimental medicine and biology. 611. 507–508. 8 indexed citations
12.
Laporte, Régent, James A. Russell, Donald W. Landry, & Pierre Rivière. (2008). Selective V1a receptor agonist FE 202158 reverses platelet-activating factor-induced hypotension, vascular leak, impaired tissue perfusion, and mortality in rats. Critical Care. 12(Suppl 2). P407–P407. 10 indexed citations
13.
Laporte, Régent, et al.. (2004). Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle. Pharmacological Reviews. 56(4). 439–513. 84 indexed citations
14.
Lee, Young‐Ho, Inkyeom Kim, Régent Laporte, Michael P. Walsh, & Kathleen G. Morgan. (1999). Isozyme‐specific inhibitors of protein kinase C translocation: effects on contractility of single permeabilized vascular muscle cells of the ferret. The Journal of Physiology. 517(3). 709–720. 52 indexed citations
15.
Laporte, Régent & Ismail Laher. (1997). Sarcoplasmic Reticulum-Sarcolemma Interactions and Vascular Smooth Muscle Tone. Journal of Vascular Research. 34(5). 325–343. 34 indexed citations
16.
Laher, Ismail, et al.. (1995). α-Toxin perfusion: a new method for selective impairment of endothelial function in isolated vessels or intact vascular beds. Canadian Journal of Physiology and Pharmacology. 73(11). 1669–1673. 2 indexed citations
17.
Laporte, Régent, Joe R. Haeberle, & Ismail Laher. (1994). Phorbol Ester-induced Potentiation of Myogenic Tone is not Associated with Increases in Ca2+ Influx, Myoplasmic Free Ca2+ Concentration, or 20-kDa Myosin Light Chain Phosphorylation. Journal of Molecular and Cellular Cardiology. 26(3). 297–302. 21 indexed citations
18.
Henrion, Daniel, Ismail Laher, Régent Laporte, & John A. Bevan. (1992). Further evidence from an elastic artery that angiotensin II amplifies noradrenaline-induced contraction through activation of protein kinase C. European Journal of Pharmacology. 224(1). 13–20. 32 indexed citations
19.
Henrion, Daniel, Ismail Laher, Régent Laporte, & J A Bevan. (1992). Angiotensin II amplifies arterial contractile response to norepinephrine without increasing Ca++ influx: role of protein kinase C.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 835–840. 52 indexed citations
20.
Laporte, Régent, et al.. (1989). Effects of exercise on skeletal muscle and serum enzyme activities in pigs. Veterinary Research Communications. 13(5). 341–347. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026